Smith & Nephew (SNN) FCF Payout Ratio (2009 - 2024)
Smith & Nephew (SNN) posted quarterly FCF Payout Ratio of 1.17 for Q4 2024, up 2.42% year-on-year from 1.15 in Q1 2024, and up 2.42% on a QoQ basis from 1.2 in Q4 2023.
Smith & Nephew (SNN) FCF Payout Ratio (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported FCF Payout Ratio for 16 consecutive years, with 1.17 the latest figure, recorded in Q4 2024.
- Quarterly FCF Payout Ratio rose 2.42% year-over-year to 1.17 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 1.58 (down 37.3% YoY) and the FY2025 annual result came in at 0.39, down 28.22% from the prior year.
- FCF Payout Ratio advanced to 1.17 in Q4 2024 per SNN's latest filing, from 1.2 in the prior quarter.
- Over the last five years, FCF Payout Ratio for SNN reached as high as 1.07 in Q4 2020 and fell as low as 1.2 in Q4 2023.
- A 5-year average of 1.16 and a median of 1.17 in 2022 frame the typical range for FCF Payout Ratio.
- Annual changes were most pronounced in 2020 — FCF Payout Ratio plunged 37.86% — and 2024, when it increased 2.42%.
- Year by year, FCF Payout Ratio stood at 1.07 in 2020, then retreated by 7.96% to 1.16 in 2021, then decreased by 0.66% to 1.17 in 2022, then dropped by 3.08% to 1.2 in 2023, then grew by 2.42% to 1.17 in 2024.
- According to Business Quant data, FCF Payout Ratio over the past three periods registered 1.17, 1.2, and 1.17 for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.20 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.81 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.44 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.14 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 0.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.17 |
| Dec 31, 2023 | -1.20 |
| Dec 31, 2022 | -1.17 |
| Dec 31, 2021 | -1.16 |
| Dec 31, 2020 | -1.07 |
| Dec 31, 2019 | -0.78 |
| Dec 31, 2018 | -0.93 |
| Dec 31, 2017 | -0.72 |
| Dec 31, 2016 | -0.71 |
| Dec 31, 2015 | -0.76 |
| Dec 31, 2014 | -0.67 |
| Mar 31, 2014 | -0.83 |
| Dec 31, 2013 | -0.79 |
| Mar 31, 2013 | -0.74 |
| Dec 31, 2012 | -3.21 |
| Jun 30, 2012 | -1.87 |
| Mar 31, 2012 | -1.14 |
| Dec 31, 2011 | -1.21 |
| Mar 31, 2011 | -1.31 |
| Dec 31, 2010 | -1.78 |